Phenotype
|
Fish
|
Conditions
|
Figures
|
notochord cobll1a expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
whole organism apoa4b.1 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
intestine fabp2 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
whole organism fabp2 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
liver fabp10a expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
exocrine pancreas prss1 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
lipid catabolic process decreased process quality, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism rargb expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism fabp10a expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
retinoic acid metabolic process decreased process quality, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism apoea expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
whole organism rarab expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism prss1 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
lipid metabolic process increased process quality, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
head decreased size, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
lipoprotein metabolic process decreased process quality, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
whole organism cobll1a expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
whole organism aldh1a2 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
intestine aldh1a2 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
intestine rdh10b expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
trunk aldh1a2 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism rarga expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism srebf2 expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism raraa expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism cyp26a1 expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism apoa1a expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
eye decreased size, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
whole organism apoa4a expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
whole organism elovl2 expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism ins expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
whole organism lpla expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism srebf1 expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
eye aldh1a2 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
endocrine pancreas ins expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
whole organism rbp4 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism apoeb expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
liver rbp4 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism cp expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
whole organism apoba expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
liver cyp26a1 expression increased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism fasn expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism apobb.1 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
coelom increased size, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
whole organism apoa1b expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
adipose tissue increased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
adipose tissue fasn expression increased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism dgat1a expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
notochord cobll1a expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 2
from Zeng et al., 2024
|
whole organism hhex expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 3
from Zeng et al., 2024
|
whole organism apoa2 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 7
from Zeng et al., 2024
|
whole organism stra6 expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism lipca expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism rdh10b expression decreased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|
whole organism scd expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
whole organism elovl6 expression increased amount, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 6
from Zeng et al., 2024
|
liver aldh1a2 expression decreased distribution, abnormal
|
cobll1ahn17/hn17 (TU)
|
standard conditions
|
FIGURE 5
from Zeng et al., 2024
|